NLRP3 CAPS mutations and model of NEK7-mediated NLRP3 inflammasome... | Download Scientific Diagram
Frontiers | Pharmacological Inhibitors of the NLRP3 Inflammasome
NLRP3 inflammasome sensor | Review | Invivogen
NLRP3 - Ventus Therapeutics
NLRP3 leucine-rich repeats control induced and spontaneous inflammasome activation in cryopyrin-associated periodic syndrome - Journal of Allergy and Clinical Immunology
Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases | Science Immunology
Frontiers | Regulation of the NLRP3 Inflammasome by Post-Translational Modifications and Small Molecules
Therapeutic effect of NLRP3 inhibition on hearing loss induced by systemic inflammation in a CAPS-associated mouse model - eBioMedicine
MCC950 | NLRP3 inflammasome inhibitor | InvivoGen
Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases | EMBO Molecular Medicine
Cells | Free Full-Text | Specific NLRP3 Inflammasome Assembling and Regulation in Neutrophils: Relevance in Inflammatory and Infectious Diseases
CAPS and NLRP3 | SpringerLink
The NLRP3 inflammasome: contributions to inflammation-related diseases | Cellular & Molecular Biology Letters | Full Text
IJMS | Free Full-Text | The NLRP3 Inflammasome: Relevance in Solid Organ Transplantation
Biomedicines | Free Full-Text | Anti-NLRP3 Inflammasome Natural Compounds: An Update
Regulation of NLRP3 Inflammasome by Phosphorylation | Semantic Scholar
Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction | Pharmacological Reviews
Cryo-sensitive aggregation triggers NLRP3 inflammasome assembly in cryopyrin-associated periodic syndrome | eLife
The NLRP3 inflammasome: regulation by metabolic signals: Trends in Immunology
NLRP3 Inflammasome as a Therapeutic Target for Atherosclerosis: A Focus on Potassium Outflow
The NLRP3 inflammasome: molecular activation and regulation to therapeutics | Nature Reviews Immunology
Targeting the NLRP3 inflammasome in inflammatory diseases | Nature Reviews Drug Discovery
An update on the regulatory mechanisms of NLRP3 inflammasome activation | Cellular & Molecular Immunology
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells | Science
NLRP3‐directed antisense oligonucleotides reduce microglial immunoactivities in vitro - Braatz - Journal of Neurochemistry - Wiley Online Library
